Characterization of basic amino acids-conjugated PAMAM dendrimers as gene carriers for human adipose-derived mesenchymal stem cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-03-30

• Fields of study

  Biology, Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.ijpharm.2016.01.063PMID 26827918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of mesenchymal stem cells in cell life and their signaling.

  2014cited by this paper
• Basic amino acid-conjugated polyamidoamine dendrimers with enhanced gene transfection efficiency

  2014cited by this paper
• Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery.

  2013cited by this paper
• Overcoming nonviral gene delivery barriers: perspective and future.

  2013cited by this paper
• Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases.

  2012cited by this paper
• Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans.

  2012cited by this paper
• Nucleic acid carriers based on precise polymer conjugates.

  2011cited by this paper
• Gene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers.

  2011cited by this paper
• Synthesis of PAMAM dendrimer derivatives with enhanced buffering capacity and remarkable gene transfection efficiency.

  2011cited by this paper
• Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues.

  2010cited by this paper
• Intracellular uptake and trafficking of difluoroboron dibenzoylmethane-polylactide nanoparticles in HeLa cells.

  2010cited by this paper
• Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells.

  2010cited by this paper
• Effect of functionalised fluorescence-labelled nanoparticles on mesenchymal stem cell differentiation.

  2010cited by this paper
• Protective effects of ginsenoside Rb3 on oxygen and glucose deprivation-induced ischemic injury in PC12 cells

  2010cited by this paper
• Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells.

  2010cited by this paper
• Gene delivery using functional dendritic polymers.

  2009cited by this paper
• Recent trends in non‐viral vector‐mediated gene delivery

  2009cited by this paper
• Gene delivery using functional dendritic polymers

  2009cited by this paper
• New opportunities: the use of nanotechnologies to manipulate and track stem cells.

  2008cited by this paper
• Guanidinylated Dendritic Molecular Transporters: Prospective Drug Delivery Systems and Application in Cell Transfection

  2008cited by this paper
• Dendrimers and the double helix--from DNA binding towards gene therapy.

  2008cited by this paper
• Labeling of mesenchymal stem cells by bioconjugated quantum dots.

  2007cited by this paper
• Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.

  2007cited by this paper
• Mesenchymal Progenitors Able to Differentiate into Osteogenic, Chondrogenic, and/or Adipogenic Cells In Vitro Are Present in Most Primary Fibroblast‐Like Cell Populations

  2007cited by this paper
• Gene Transfer into Rat Mesenchymal Stem Cells: A Comparative Study of Viral and Nonviral Vectors

  2006cited by this paper
• Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells.

  2006cited by this paper
• Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery

  2006cited by this paper
• Toxicity of cationic lipids and cationic polymers in gene delivery.

  2006cited by this paper
• Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.

  2006cited by this paper
• Designing dendrimers for biological applications

  2005cited by this paper
• Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery.

  2005cited by this paper
• Determination of cell lysis and death kinetics in continuous hybridoma cultures from the measurement of lactate dehydrogenase release

  2004cited by this paper
• Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine.

  2004cited by this paper
• DNA nanoparticles and development of DNA delivery vehicles for gene therapy.

  2002cited by this paper
• Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy.

  2002cited by this paper
• Biological applications of dendrimers.

  2002cited by this paper
• Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

  2000cited by this paper
• Synthetic DNA delivery systems

  2000cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.

  1987cited by this paper

• Biomaterial-Based Nucleic Acid Delivery Systems for In Situ Tissue Engineering and Regenerative Medicine

  2025cites this paper
• Self-Assembly of a Novel Pentapeptide into Hydrogelated Dendritic Architecture: Synthesis, Properties, Molecular Docking and Prospective Applications

  2024cites this paper
• Synthesis and application of poly(amidoamine) functional biomedical materials in the field of biomedicine over the past decade

  2024cites this paper
• Dendritic Polymers in Tissue Engineering: Contributions of PAMAM, PPI PEG and PEI to Injury Restoration and Bioactive Scaffold Evolution

  2023cites this paper
• Dendrimer as a momentous tool in tissue engineering and regenerative medicine.

  2022cites this paper
• Polyplexes for Gene and Nucleic Acid Delivery: Progress and Bottlenecks.

  2020cites this paper
• Dendrimers for drug delivery purposes

  2020cites this paper
• Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by HA for targeted gene delivery systems and evaluation in vitro

  2020cites this paper
• Nonviral Gene Therapy: Peptiplexes

  2019cites this paper
• 68Ga tagged dendrimers for molecular tumor imaging in animals.

  2019cites this paper
• Electroporation: A Sustainable and Cell Biology Preserving Cell Labeling Method for Adipogenous Mesenchymal Stem Cells

  2019cites this paper
• 3D hydrogel stem cell niche controlled by host-guest interaction affects stem cell fate and survival rate.

  2019cites this paper
• Nucleic Acid Nanotheranostics: Biomedical Applications

  2019cites this paper
• Enhanced Delivery of Plasmid DNA to Skeletal Muscle Cells using a DLC8-Binding Peptide and ASSLNIA-Modified PAMAM Dendrimer.

  2019cites this paper
• Electrostatically assembled dendrimer complex with a high‐affinity protein binder for targeted gene delivery

  2018cites this paper
• Nanocarriers in Drug and Gene Delivery

  2018cites this paper
• Fabrication of Fe3O4@polydopamine@polyamidoamine core–shell nanocomposites and their application for Cu(II) adsorption

  2018cites this paper
• Dendrimers: Smart nanoengineered polymers for bioinspired applications in drug delivery

  2017cites this paper
• Hybrid supramolecular gels of Fmoc-F/halloysite nanotubes: systems for sustained release of camptothecin.

  2017cites this paper
• Potential Therapeutic Applications of Adipose-Derived Mesenchymal Stem Cells

  2016cites this paper
• Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer.

  2016cites this paper